USP 800 Lisa Lasita, PharmD, MBA Director of Pharmacy

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Common/shared responsibilities between jobs.
Tips to a Successful Monitoring Visit
Safety Standards Workgroup: Meeting One Mona K. Gahunia, DO DHMH Chief Medical Officer July 9, 2014.
Successful Solutions Professional Development LLC Chapter 3 Medication Management.
The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht.
Governor’s Secure Commonwealth Initiative, Health and Human Resources Sub-Panel Meeting Janis Ober MSN RN CIC Director, Infection Prevention.
Personal Protective Equipment Use in Chemotherapy Administration
Chapter 11 Safety and Health Elsevier items and derived items © 2009, 2005 by Saunders, an imprint of Elsevier Inc.
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
Emergency Management Working Group 10 November 2014 Please remember to silence your cell phone.
Quality Assurance/Quality Control Policy
2008© COPYRIGHT 1 1 ATHN DATA SUMMIT DISASTER PREPAREDNESS JULY 31, 2008 PANEL MEMBER - JOY MAHURIN COMPREHENSIVE BLEEDING DISORDERS CENTER CONTINUITY.
Sandia is a multi-program laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy’s National Nuclear.
NC A&T STATE UNIVERSITY
Component 2: The Culture of Health Care Unit 3: Health Care Settings— The Places Where Care Is Delivered Lecture 3 This material was developed by Oregon.
NORTH AMERICAN SAFETY CHECKLIST – SB 158. Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc. Presented By:
Implementing ISO 9001 Our project plan Copyright ©2008 The 9000 Store.
Services and Supplies to Meet USP Requirements Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Pharmacy.
Compounding Issues in Neuromodulation December 9, 2012 North American Neuromodulation Society 16 th Annual Scientific Meeting Wynn Hotel, Las Vegas Nevada.
Horizontal Laminar Air Flow Vertical Laminar Air Flow.
1293 Airport Road, Beaver, WV Phone: (304) Fax: (304) HAZWOPER MEDICAL SURVEILLANCE International.
By Vickie Kirkley, RN. Director of Materials Management/ Central Supply/ Central Sterile Job Requirements Career / Job Requirements Bachelor of Science.
Strategic Human Resource Management SHRM. Public administration must meet the challenge of changing social needs and priorities, new directions in public.
Performing Hospital Waste Audits Presented by Peggy Harlow, WM Healthcare Solutions, Inc. April 2, 2012.
Compounding Kenneth Schell Pharm. D President, CA State Board of Pharmacy.
Introduction to Hazard Communication An Employee Orientation & Training Course ?
PHARMACY IV ADMIXTURE Pharmacy 483 January 18, 2005 Kim Donnelly Affiliate Associate Professor.
Minnesota Department of Health Assisted Living Home Care Provider Licensing Surveys Surveys Conducted May – October 2005 © Care Providers of Minnesota.
Introduction In 2005, comparisons were made internally by word of mouth and externally with other Tenet Healthcare Corporation hospitals, Georgia Hospitals.
© 2009 Delmar, Cengage Learning Chapter 3 Home Health Care.
Hazardous and Infectious Waste. Managing hazardous waste Hazardous waste includes chemicals and biological materials Disposal of waste in the health care.
Mike Riepl Director of Compounding Services Gateway HealthMart Pharmacy 3101 N 11 th St, Ste #2 Bismarck, ND
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Testing and Safety Regulations for Hazardous Drug Compounding
BRITTANY HAGEN BS RN OCN CCRC CLINICAL RESEARCH MANAGER OHC, INC. OHC Research.
Hazard Communication City of Burlington. Introduction What’s it all about: Workplace chemical usage How we use them How we protect ourselves Chemical.
HS460 Project Design and Management for Healthcare Lori Seargeant, MA, RHIA.
NC A&T STATE UNIVERSITY
Lou Diorio, RPh, FAPhA Principal LDT Health Solutions, Inc.
USP 800 Implementation in a Community Oncology Practice
CHEMOTHERAPY PREPARATION
Patricia C. Kienle, RPh, MPA, FASHP
USP 797 Guidelines: Compounding Areas and Equipment
洗手及 负压技术 余 波
Quality Control and Assurance
John Karwoski, RPh, MBA President and Founder JDJ Consulting, LLC
pharmacy store location---good location and signs
Practice with Confidence
Compounding.
USP <797> and <800> Update
USP 797 & USP 800: Updates Are Coming… Are You Prepared?
Disaster Relief – You and Your Emergency Preparedness Plan
Outline Why Focus on PN Safety? PN Safety Gap Analysis Survey Results
Controlled Substances
Chemical Safety and Security Plan
Controlled Substances
Antineoplastic medications: Non-antineoplastic medications:
ESS Handbook for Radiation Protection
Biocontainment Patient Care Unit— Medical Care Issues
EPA Worker Protection Training
Controlled Substances
Regulatory and Compliance
Safety in Medication Administration
OSHA’s Respiratory Protection: Final Rule 29 CFR Part 1910
Ebola Facts October 16, 2014.
ENSURING YOUR PRACTICE IS USP 800 COMPLIANT
Kerry Maloney, Esq., General Counsel, and
Ebola Facts October 16, 2014.
Presentation transcript:

USP 800 Lisa Lasita, PharmD, MBA Director of Pharmacy Oncology Hematology Care, Inc Kyle T. Brown, CPhT Infusion & Spec. Retail Purchaser Zangmeister Center

Agenda Review OHC’s and Zangmeister’s pharmacy operations Quick review of the standards Steps to take to meet the standards OHC’s progress and pain points Zangmeister’s progress and pain points

OHC 12 locations that operate under a physician dispensing license 1 licensed retail pharmacy 24 Medical Oncologists 11 Radiation Oncologists 3 Gynecologic Oncologists

Zangmeister One all-encompassing site Specialty Retail Pharmacy 14 Medical Oncologists 1 Gynecologic Oncologists Radiology Department Accessible Radiation Oncology

United States Pharmacopeia 800 New Official Compliance Date December 1, 2019 Ohio has its own set of rules that went into effect May 1, 2016 for hazardous drugs compounded by a prescriber Main goal: Protect employees, and patients, during the transport, storage, preparation, dispensing, and administration

Becoming Compliant Form a multidisciplinary team Assign 1 person to be the project lead Perform a gap analysis Develop an action plan

Gap Analysis Divide and conquer amongst team Physical requirements Hoods Facilities: Receipt/Storage of drug Personal Protective Equipment (PPE) Closed System Transfer Devices Hood: Deactivation/Cleaning/ Decontamination/Disinfecting

Action Plan Address each gap individually Update policies and procedures Educate/Train Staff Include a cost analysis Must include a timeline

Hazardous Drug List Start with NIOSH list You can expand the hazardous drug list to meet your organizations needs We revised 3 times as staff had questions/opinions Need a plan for evaluating new drugs Need to update hazardous drug list annually

Closed System Transfer Devices (CSTD) Must be used during administration Should be used while compounding Trial 2-3 devices Complete a cost analysis

PPE This was a big gap for us that required additional training as staff was resistant Garbing technique is important to minimize exposure. Consider Annual Garbing Competency Compounding: Gown, gloves (double), shoe covers, bouffant, mask, eye protection Handling/Receiving: Full Garb Spill: Full garb plus N-95 approved respiratory protection Administration: Gown, gloves (double)

N-95 Approved Respiratory Protection Need to get staff FIT tested Need to select and then stock all sizes of the N-95 approved masks Need to FIT test staff annually and keep list Work with PPE vendor for FIT test supplies

How OHC has tackled USP 800 4 person team including Nursing Pharmacy Facilities/Building Gap analysis completed Cost analysis completed Action plan put together

OHC’s Action Items Update policies and procedures for the following: PPE Cleaning/Disinfecting/Decontaminating etc. Label Requirement Beyond use date of 12 hours Educate/Train staff on updates Create hazardous drug list Trial and select CSTD FIT test employees

OHC’s Action Items This is by far our biggest challenge Need a plan for each building in regards to: HVAC: Positive and negative pressure C-PEC: External venting C-SEC: Hazardous vs non-hazardous areas Storage/Receipt Designated receiving area Separate refrigerators Separate drug storage cabinets This is by far our biggest challenge

OHC’s Next Steps Engage team Revisit plan and gap analysis Retrain if gaps still exist Finalize building plans/physical requirements Need to make sure building plans are part of the 5 and 10 year strategic plan Cost to get all buildings compliant? Evaluate centralized mixing, is it feasible?

How Zangmeister Accomplished USP 800 Building was constructed to be USP 797 compliant Identify where your strengths and weaknesses lie Make a point person Divide out action points into similar areas of change Phase in change in increments Build upon existing SOP, stage mock audits, HD spill drill and evaluate

Purchasing Tips Define items for change and addition Work closely with your Medical Supply Co rep- use this free resource Bid out current catalog’s purchase volume Leverage volume, entirety, and future USP items Focus on CSTD and other high spend/high frequency items Wipes- HD clean, Peridox, etc dwell time Should we do a chemo surface test?

Recommended Action Items to be Compliant Read USP 800 Read OAC Rule: 4729-16-11 Identify team members Complete gap analysis Create an action plan Define hazardous drug list Evaluate/Update policies and procedures Evaluate HVAC, PEC, SEC, and PPE Evaluate and choose a CSTD Create and/or update training program

Helpful USP 800 Resources NIOSH List OAC: 4729-16-11 https://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf https://www.cdc.gov/niosh/topics/hazdrug/default.html OAC: 4729-16-11 http://codes.ohio.gov/oac/4729-16-11 ASHP Chapter 800 Answer Book https://store.ashp.org/Default.aspx?TabID=251&productId=557160751

Questions lisa.lasita@usoncology.com kbrown@zangcenter.com